A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Acute Lymphoblastic Leukemia · Non-Hodgkin Lymphoma of Soft Tissue

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Contact: Study coordinator (He Huang, PhD) · hehuangyu@126.com · 86-13605714822

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of CTA101 UCAR-T Cell Injection in Patients With Relapsed or Refractory CD19+ B-line Hematological Malignancy

Acute Lymphoblastic Leukemia · Non-hodgkin Lymphoma

Abroad (travel likely)RecruitingEARLY_PHASE1

Hangzhou, China

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Duarte, United States · Atlanta, United States

PTCy and ATG for MSD and MUD Transplants

Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rio de Janeiro, Brazil